0
0
Findings Published in JAMA Oncology Demonstrate Superiority of MRIdian® MRI-Guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer - PR Newswire
1/12/23 at 4:53pm
Organization
PRNewswire
42 words
0
Comments
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that findings from the phase III randomized controlled MIRAGE trial (NCT04384770) were published...
You are the first to view
https://www.prnewswire.com/news-releases/findings-published-in-jama-oncology-demonstrate-superiority-of-mridian-mri-guidance-in-stereotactic-body-radiotherapy-sbrt-for-localized-prostate-cancer-301720570.html
Create an account or login to join the discussion